In the News
CHCWM’s Muskegon Group is on the Move – August 26
06/24/2019
CHC is proud to announce that we’re still growing, and that means a new, bigger facility for our Muskegon group! We will be moving on August 26 to our new location at 6425 South Harvey Street. For More Details Read more »
CHCWM’s Involvement in Resilient Trials & ASCO Announcement
05/31/2019
RESILIENT trial results will be released in lung cancer poster section on this Sunday morning (June 2, 2019) at ASCO annual meeting. CHCWM is the 3rd largest recruiter on the planet and the largest recruiter in the US. Excellent work Read more »
CHCWM’s Dr. Yuanbin Chen – Journal of Thoracic Oncology
05/22/2019
CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”. Read the Article Read more »
CHCWM – START Midwest article in Yahoo Finance
05/21/2019
CHC’s START Midwest program is in on another Phase I clinical trial making the news. Read the Article Read more »
CHCWM – Publication in the American Journal of Managed Care
05/20/2019
CHC’s Wendy Koopman (Clinical Director and Nurse Practitioner), for her work on the Evidence Based Oncology – Adverse Event Tracking article, featured in the April 2019 issue of The American Journal of Managed Care. Read the Article Read more »
START Midwest – Publication in the Journal of Clinical Oncology
03/14/2019
CHC’s Dr. Chandana, Dr. Lakhani, and Dr. O’Rourke, in their work with our START Midwest Phase I Clinical trials, are featured in the February 27, 2019 issue of The Journal of Clinical Oncology. Read the Study Read more »